293 related articles for article (PubMed ID: 19226146)
1. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
[TBL] [Abstract][Full Text] [Related]
2. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
[TBL] [Abstract][Full Text] [Related]
5. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
[TBL] [Abstract][Full Text] [Related]
6. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain.
Jia Z; Petrounevitch V; Wong A; Moldoveanu T; Davies PL; Elce JS; Beckmann JS
Biophys J; 2001 Jun; 80(6):2590-6. PubMed ID: 11371436
[TBL] [Abstract][Full Text] [Related]
7. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
[TBL] [Abstract][Full Text] [Related]
8. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
[TBL] [Abstract][Full Text] [Related]
10. Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?
Pizzanelli C; Mancuso M; Galli R; Choub A; Fanin M; Nascimbeni AC; Siciliano G; Murri L
Neurol Sci; 2006 Jun; 27(2):134-6. PubMed ID: 16816913
[TBL] [Abstract][Full Text] [Related]
11. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.
Duno M; Sveen ML; Schwartz M; Vissing J
Eur J Hum Genet; 2008 Aug; 16(8):935-40. PubMed ID: 18337726
[TBL] [Abstract][Full Text] [Related]
12. Calpains in muscle wasting.
Bartoli M; Richard I
Int J Biochem Cell Biol; 2005 Oct; 37(10):2115-33. PubMed ID: 16125114
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional explorations of CAPN3 identify novel splicing mutations, a large-sized genomic deletion and evidence for messenger RNA decay.
Krahn M; Pécheux C; Chapon F; Béroud C; Drouin-Garraud V; Laforet P; Romero NB; Penisson-Besnier I; Bernard R; Urtizberea JA; Leturcq F; Lévy N
Clin Genet; 2007 Dec; 72(6):582-92. PubMed ID: 17979987
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A).
Kramerova I; Beckmann JS; Spencer MJ
Biochim Biophys Acta; 2007 Feb; 1772(2):128-44. PubMed ID: 16934440
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A.
Benayoun B; Baghdiguian S; Lajmanovich A; Bartoli M; Daniele N; Gicquel E; Bourg N; Raynaud F; Pasquier MA; Suel L; Lochmuller H; Lefranc G; Richard I
FASEB J; 2008 May; 22(5):1521-9. PubMed ID: 18073330
[TBL] [Abstract][Full Text] [Related]
16. Calpain 3: a key regulator of the sarcomere?
Duguez S; Bartoli M; Richard I
FEBS J; 2006 Aug; 273(15):3427-36. PubMed ID: 16884488
[TBL] [Abstract][Full Text] [Related]
17. Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?
Sáenz A; Ono Y; Sorimachi H; Goicoechea M; Leturcq F; Blázquez L; García-Bragado F; Marina A; Poza JJ; Azpitarte M; Doi N; Urtasun M; Kaplan JC; López de Munain A
Muscle Nerve; 2011 Nov; 44(5):710-4. PubMed ID: 22006685
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic procedure of limb girdle muscular dystrophies 2A or calpainopathies: French cohort from a neuromuscular center (Bordeaux)].
Perez F; Vital A; Martin-Negrier ML; Ferrer X; Sole G
Rev Neurol (Paris); 2010 May; 166(5):502-8. PubMed ID: 20044116
[TBL] [Abstract][Full Text] [Related]
19. Limb-girdle muscular dystrophy type 2A.
Pradhan S
Neurol India; 2010; 58(4):509-11. PubMed ID: 20739783
[No Abstract] [Full Text] [Related]
20. Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy.
Shin JH; Kim HS; Lee CH; Kim CM; Park KH; Kim DS
J Korean Med Sci; 2007 Jun; 22(3):463-9. PubMed ID: 17596655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
